DW14383 is an irreversible pan-FGFR inhibitor that suppresses FGFR-dependent tumor growth in vitro and in vivo
Mengdi Dai(Chinese Academy of Sciences), Jing Ai(Baoshan College)
Cited by 10
Related Papers
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models
|Journal of Experimental & Clinical Cancer Research|2019|32